default author photo

Nadia Storm

Boston University - Department of Microbiology

595 Commonwealth Avenue

Boston, MA 02215

United States

SCHOLARLY PAPERS

1

DOWNLOADS

62

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022

Number of pages: 15 Posted: 01 Jun 2020
Caroline Atyeo, Matthew D. Slein, Stephanie Fischinger, John Burke, Alexandra Schӓfer, Sarah R. Leist, Anna Honko, Rebecca Johnson, Nadia Storm, Matthew Bernett, Caitlyn Linde, Todd Suscovich, Anthony Griffiths, John R. Desjarlais, Boris D. Juelg, Jaap Goudsmit, Ralph Baric and Galit Alter
Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Boston University - Department of Microbiology, Boston University - Department of Microbiology, Boston University - Department of Microbiology, Xencor, SeromYx Systems, SeromYx Systems, Boston University - Department of Microbiology, Xencor, Ragon Institute of MGH, MIT and Harvard, Harvard University - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology and Ragon Institute of MGH, MIT and Harvard
Downloads 62 (942,565)
Citation 1

Abstract:

Loading...

SARS-CoV-2, antibody effector function, immunity, Fc function, CR3022